Israel's Immune Pharma waves the white flag after failing to secure deals for inflammation drug
An eosinophil regulating drug that’s traveled down a winding path to the clinic is once again set to switch hands.
Immune Pharma, which first in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
